{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:08:50Z","timestamp":1769306930375,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.drugpo.2011.09.001","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T17:19:52Z","timestamp":1318871992000},"page":"333-337","source":"Crossref","is-referenced-by-count":39,"title":["Transition to injection amongst opioid users in Iran: Implications for harm reduction"],"prefix":"10.1016","volume":"23","author":[{"given":"Mohsen","family":"Malekinejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Vazirian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.drugpo.2011.09.001_bib0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1360-0443.2006.01379.x","article-title":"Some characteristics of early-onset injection drug users prior to and at the time of their first injection","volume":"101","author":"Abelson","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2011.09.001_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugpo.2010.01.011","article-title":"Route transition interventions: Potential public health gains from reducing or preventing injecting","volume":"21","author":"Bridge","year":"2010","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-7517-3-10","article-title":"Risk factors associated with injection initiation among drug users in Northern Thailand","volume":"3","author":"Cheng","year":"2006","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0020","unstructured":"DCHQ. (2011a). News dated 22nd June 2011. In Farsi. Retrieved from http:\/\/www.dchq.ir"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0025","unstructured":"DCHQ. (2011b). News dated 8th March 2011. In Farsi. Retrieved from http:\/\/www.dchq.ir"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0030","series-title":"Young people and drugs \u2013 Towards a comprehensive health promotion policy, final report","author":"De Kort","year":"2005"},{"issue":"5","key":"10.1016\/j.drugpo.2011.09.001_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1360-0443.2007.01764.x","article-title":"The transition from injection to non-injection drug use: Long-term outcomes among heroin and cocaine users in New York City","volume":"102","author":"Des Jarlais","year":"2007","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugpo.2011.09.001_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1360-0443.1992.tb01950.x","article-title":"AIDS and the transition to illicit drug injection \u2013 Results of a randomized trial prevention program","volume":"87","author":"Des Jarlais","year":"1992","journal-title":"British Journal of Addiction"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2011.09.001_bib0045","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1002\/hep.1840360727","article-title":"Prevention and treatment of hepatitis C in injection drug users","volume":"36","author":"Edlin","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2011.09.001_bib0050","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/427441","article-title":"Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users","volume":"40","author":"Edlin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.drugpo.2011.09.001_bib0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10461-008-9452-7","article-title":"HIV\/AIDS epidemic features and trends in Iran, 1986\u20132006","volume":"13","author":"Fallahzadeh","year":"2009","journal-title":"AIDS and Behaviour"},{"issue":"4","key":"10.1016\/j.drugpo.2011.09.001_bib0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2105\/AJPH.2003.02178","article-title":"Effects of race, neighborhood, and social network on age at initiation of injection drug use","volume":"95","author":"Fuller","year":"2005","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2011.09.001_bib0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jurban\/jth084","article-title":"Hepatitis C incidence \u2013 A comparison between injection and noninjection drug users in New York City","volume":"81","author":"Fuller","year":"2004","journal-title":"Journal of Urban Health"},{"issue":"2","key":"10.1016\/j.drugpo.2011.09.001_bib0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0376-8716(01)00200-9","article-title":"High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case\u2013control study","volume":"66","author":"Fuller","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2011.09.001_bib0075","first-page":"318","article-title":"Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran","volume":"13","author":"Hosseini","year":"2010","journal-title":"Archives of Iranian Medicine"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0080","unstructured":"INCB. (2010). The report of the International Narcotics Control Board (INCB) for 2009. Retrieved from http:\/\/www.incb.org\/incb\/en\/annual-report-2009.html"},{"issue":"2","key":"10.1016\/j.drugpo.2011.09.001_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0376-8716(96)01262-8","article-title":"Crack cocaine smokers who turn to drug injection: Characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team","volume":"42","author":"Irwin","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"issue":"2.","key":"10.1016\/j.drugpo.2011.09.001_bib0090","article-title":"Socio-cultural factors associated with the initiation of opium use in Darab, Iran","volume":"7","author":"Jafari","year":"2009","journal-title":"International Journal of Mental Health and Addiction"},{"issue":"10","key":"10.1016\/j.drugpo.2011.09.001_bib0095","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.socscimed.2003.08.006","article-title":"Effects of drug treatment for heroin sniffers: A protective factor against moving to injection?","volume":"58","author":"Kelley","year":"2004","journal-title":"Social Science and Medicine"},{"issue":"9","key":"10.1016\/j.drugpo.2011.09.001_bib0100","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1360-0443.2008.02249.x","article-title":"Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS","volume":"103","author":"Lawrinson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0105","unstructured":"Malekinejad, M., Mohraz, M., Razani, N., Khairandish, P., McFarland, W., Akbari, G., et al. (2008). Assessment of the use of respondent-driven sampling for studying populations most at risk of HIV infection [Doctoral Dissertation]. School of Public Health: University of California, Berkeley."},{"key":"10.1016\/j.drugpo.2011.09.001_bib0110","series-title":"Oral presentation, XVII International AIDS Conference, Mexico City, August 2008","article-title":"HIV and related risk behaviors of injecting drug users (IDU) in Iran: Findings from the first respondent-driven sampling (RDS) survey of IDU in Tehran in 2006\u20132007","author":"Malekinejad","year":"2008"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0115","series-title":"Ministry of Health and Medical Education (MOHME)","author":"MOHME","year":"2006"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0120","series-title":"Islamic republic of Iran country report on monitoring of the United Nations general assembly special session on HIV and AIDS, February 2010: National AIDS Committee Secretariat","author":"MOHME","year":"2010"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0125","series-title":"Statistics of HIV\/AIDS in islamic republic of Iran: Quarterly, August 2010: Center for disease management","author":"MOHME\/CD.M.","year":"2010"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0130","series-title":"The annual report of substance abuse treatment and prevention office (SAPTO)","author":"MOHME\/SAPT.O.","year":"2010"},{"issue":"3","key":"10.1016\/j.drugpo.2011.09.001_bib0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.drugpo.2008.02.001","article-title":"The social context of initiation into injecting drugs in the slums of Makassar, Indonesia","volume":"20","author":"Nasir","year":"2009","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0140","unstructured":"Nassirimanesh, B., Trace, M., & Roberts, M. (2005). The rise of harm reduction in the Islamic Republic of Iran. Retrieved from http:\/\/www.internationaldrugpolicy.net\/publications.htm"},{"issue":"4","key":"10.1016\/j.drugpo.2011.09.001_bib0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.qai.0000186391.49205.3b","article-title":"Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility","volume":"41","author":"Neaigus","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"10.1016\/j.drugpo.2011.09.001_bib0150","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1360-0443.2001.9668476.x","article-title":"Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors","volume":"96","author":"Neaigus","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2206.2006.00449.x","article-title":"When parents use drugs: Key findings from qualitative research on parenting and children in Iran","volume":"12","author":"Pirsaraee","year":"2007","journal-title":"Child and Family Social Work"},{"issue":"1","key":"10.1016\/j.drugpo.2011.09.001_bib0165","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.ijid.2009.03.002","article-title":"HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran","volume":"14","author":"Rahimi-Movaghar","year":"2010","journal-title":"International Journal of Infectious Diseases"},{"issue":"9","key":"10.1016\/j.drugpo.2011.09.001_bib0170","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1360-0443.2007.01914.x","article-title":"HIV risk behavior among injection drug users in Tehran, Iran","volume":"102","author":"Razani","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7517-3-12","article-title":"Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran","volume":"3","author":"Razzaghi","year":"2006","journal-title":"Harm Reduction Journal"},{"issue":"9534","key":"10.1016\/j.drugpo.2011.09.001_bib0180","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(06)69132-0","article-title":"HIV\/AIDS harm reduction in Iran","volume":"368","author":"Razzaghi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0185","series-title":"Rapid situation assessment of drug abuse in Iran","author":"Razzaghi","year":"1999"},{"issue":"1","key":"10.1016\/j.drugpo.2011.09.001_bib0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jurban\/jtg092","article-title":"Drug injection among street youths in Montreal: Predictors of initiation","volume":"80","author":"Roy","year":"2003","journal-title":"Journal of Urban Health"},{"issue":"5","key":"10.1016\/j.drugpo.2011.09.001_bib0195","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11524-006-9059-0","article-title":"Risk factors associated with the transition from heroin sniffing to heroin injection: A street addict role perspective","volume":"83","author":"Sanchez","year":"2006","journal-title":"Journal of Urban Health"},{"issue":"2","key":"10.1016\/j.drugpo.2011.09.001_bib0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jurban\/79.2.266","article-title":"Drug users\u2019 involvement in the drug economy: Implications for harm reduction and HIV prevention programs","volume":"79","author":"Sherman","year":"2002","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7517-2-13","article-title":"Drug use and harm reduction in Afghanistan","volume":"2","author":"Todd","year":"2005","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0210","unstructured":"UNAIDS. (2008). Iran UNGASS report 2008. Retrieved from http:\/\/data.unaids.org\/pub\/Report\/2008\/iran_2008_country_progress_report_en.pdf"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0215","unstructured":"UNODC. (2007). Afghanistan opium survey 2007. Executive summary. http:\/\/www.unodc.org\/pdf\/research\/AFG07_ExSum_web.pdf."},{"key":"10.1016\/j.drugpo.2011.09.001_bib0220","unstructured":"UNODC. (2008). Epidemiology of drug use in Iran. Retrieved from http:\/\/www.unodc.org\/iran\/en\/epidemiology.html"},{"issue":"12","key":"10.1016\/j.drugpo.2011.09.001_bib0225","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/oxfordjournals.aje.a116962","article-title":"Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users","volume":"139","author":"van Ameijden","year":"1994","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0230","series-title":"Young people and drugs towards a comprehensive health promotion policy: Tehran report","author":"Vazirian","year":"2006"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-7517-2-19","article-title":"Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study","volume":"2","author":"Vazirian","year":"2005","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"10.1016\/j.drugpo.2011.09.001_bib0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.qai.0000219788.73539.47","article-title":"Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users","volume":"42","author":"Vickerman","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"10.1016\/j.drugpo.2011.09.001_bib0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jurban\/jth083","article-title":"Updating the infection risk reduction hierarchy: Preventing transition into injection","volume":"81","author":"Vlahov","year":"2004","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0250","unstructured":"WHO\/EMRO. (2007). RSA2 study by Drug Control Head Quarter (DCHQ) in 2007. Retrieved from http:\/\/www.emro.who.int\/asd\/Media\/excel\/Iran.xls"},{"issue":"7","key":"10.1016\/j.drugpo.2011.09.001_bib0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.aids.0000166094.24069.72","article-title":"Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran","volume":"19","author":"Zamani","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2011.09.001_bib0260","series-title":"Poster presentation, 7th International Congress on AIDS in Asia and Pacific","article-title":"HIV-1 prevalence and sexual characteristics of injecting drug users visiting treatment centers in Tehran, Iran: A potential bridge of HIV-1 infection from IDU to their sexual partners","author":"Zamani","year":"2005"},{"issue":"3","key":"10.1016\/j.drugpo.2011.09.001_bib0265","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.qai.0000219785.81163.67","article-title":"High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran","volume":"42","author":"Zamani","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"5","key":"10.1016\/j.drugpo.2011.09.001_bib0270","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.drugpo.2007.02.007","article-title":"Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran","volume":"18","author":"Zamani","year":"2007","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2011.09.001_bib0275","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10461-008-9404-2","article-title":"Needle and syringe sharing practices among injecting drug users in Tehran: A comparison of two neighborhoods, one with and one without a needle and syringe program","volume":"14","author":"Zamani","year":"2008","journal-title":"AIDS and Behaviour"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395911001630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395911001630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T16:12:50Z","timestamp":1560787970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395911001630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0955395911001630"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2011.09.001","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}